Loading clinical trials...
Loading clinical trials...
An Intergroup Phase II Clinical Trial for Adolescents and Young Adults With Untreated Acute Lymphoblastic Leukemia (ALL)
Conditions
Interventions
cyclophosphamide
cytarabine
+9 more
Start Date
March 12, 2008
Primary Completion Date
September 1, 2016
Last Updated
August 18, 2021
NCT05564390
NCT06846671
NCT07320235
NCT06514534
NCT05475925
NCT07218341
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions